D040262Chemicals & DrugsD08.811.913.696.620.682.725.400.950D12.776.543.750.060.750D12.776.543.750.750.400.91012200.990543Receptors, Vascular Endothelial Growth FactorFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.5528460.022675612research area of0.5738040.045784222subject area for24685058Bitting RL, Healy P, Creel PA, Turnbull J, Morris K, Wood SY, Hurwitz HI, Starr MD, Nixon AB, Armstrong AJ, George DJClinical genitourinary cancerBitting RL, Healy P, Creel PA, Turnbull J, Morris K, Wood SY, Hurwitz HI, Starr MD, Nixon AB, Armstrong AJ, George DJ. A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma. Clin Genitourin Cancer. 2014 Aug; 12(4):241-50.Clin Genitourin Cancer2013-11-14T00:00:002013A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma.24842548Mittal K, Koon H, Elson P, Triozzi P, Dowlati A, Chen H, Borden EC, Rini BICancer biology & therapyMittal K, Koon H, Elson P, Triozzi P, Dowlati A, Chen H, Borden EC, Rini BI. Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers. . 2014 Aug; 15(8):975-81.2014-05-19T00:00:002014Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.Wake Forest School of MedicineGiuseppeOrlandoGiuseppe Orlando MD, PhD36.08959100000000-80.268599000000001226Orlando, GiuseppeAssociate ProfessorGlennLesserGlenn J. Lesser MD36.08919100000000-80.26677800000000315Lesser, GlennProfessorShaySokerShay Soker PhD36.08943500000000-80.26863200000000939Soker, ShayProfessor26470894Lesser GJOncology (Williston Park, N.Y.)Lesser GJ. Bevacizumab and Glioblastoma: The Ecstasy and the Agony. Oncology (Williston Park). 2015 Oct; 29(10):728-9.Oncology (Williston Park)2015-10-01T00:00:002015Bevacizumab and Glioblastoma: The Ecstasy and the Agony.26907516Harkins KA, Haschke M, Do DVImmunotherapyHarkins KA, Haschke M, Do DV. Aflibercept for the treatment of diabetic macular edema. Immunotherapy. 2016 05; 8(5):503-10.Immunotherapy2016-02-24T00:00:002016Aflibercept for the treatment of diabetic macular edema.Caio MaxRocha LimaCaio Max S. Rocha Lima MD, MS2211Rocha Lima, Caio MaxProfessor20ProfessorInternal Medicine, Hematology & OncologySurgery, TransplantWake Forest Institute for Regenerative Medicinetrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor18463314Saban MR, Backer JM, Backer MV, Maier J, Fowler B, Davis CA, Simpson C, Wu XR, Birder L, Freeman MR, Soker S, Hurst RE, Saban RAmerican journal of physiology. Renal physiologySaban MR, Backer JM, Backer MV, Maier J, Fowler B, Davis CA, Simpson C, Wu XR, Birder L, Freeman MR, Soker S, Hurst RE, Saban R. VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation. Am J Physiol Renal Physiol. 2008 Jul; 295(1):F60-72.Am J Physiol Renal Physiol2008-05-07T00:00:002008VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation.PierreTriozziPierre L. Triozzi MD36.09103700000000-80.269096000000001638Triozzi, PierreProfessor